{"id":385902,"date":"2022-09-29T00:00:00","date_gmt":"2022-09-29T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360ic0115-medtech-interventional-cardiology-devices-market-insights-asia-pacific-2022\/"},"modified":"2026-04-15T09:04:45","modified_gmt":"2026-04-15T09:04:45","slug":"m360ic0115-medtech-interventional-cardiology-devices-market-insights-asia-pacific-2022","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360ic0115-medtech-interventional-cardiology-devices-market-insights-asia-pacific-2022\/","title":{"rendered":"Interventional Cardiology Devices | Market Insights | Asia Pacific | 2022"},"content":{"rendered":"<p>Despite the negative\u00a0impact of the\u00a0COVID-19\u00a0pandemic in the short term, the Asia Pacific\u00a0IC\u00a0device market will grow modestly driven by improving healthcare infrastructure, growing demand, and increasing availability of clinical data supporting the adoption of next-generation\u00a0DES,\u00a0BRS,\u00a0CTO-specific devices and advanced imaging techniques later in the forecast period, increasing\u00a0PCI\u00a0volumes, and the recent increase of the price ceiling for coronary stents in the large Chinese market will all contribute to overall expansion through 2030. However, lack of reimbursement, cost constraints, and the impact of\u00a0COVID-19\u00a0pandemic will limit market growth to some extent.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for\u00a0IC\u00a0devices in Asia Pacific across a 11-year period.<\/p>\n","protected":false},"template":"","class_list":["post-385902","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-interventional-cardiology-devices","medtech-geography-asia-pacific","medtech-date-967"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385902\/revisions"}],"predecessor-version":[{"id":387412,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385902\/revisions\/387412"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=385902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}